- Home
- RIVN vs TECH Comparison
RIVN vs TECH Comparison
Compare RIVN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIVN
- TECH
- Stock Information
- Founded
- RIVN 2009
- TECH 1976
- Country
- RIVN United States
- TECH United States
- Employees
- RIVN N/A
- TECH 3100
- Industry
- RIVN Auto Manufacturing
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RIVN Consumer Discretionary
- TECH Health Care
- Exchange
- RIVN Nasdaq
- TECH Nasdaq
- Market Cap
- RIVN 13.3B
- TECH 12.0B
- IPO Year
- RIVN 2021
- TECH 1989
- Fundamental
- Price
- RIVN $14.21
- TECH $75.83
- Analyst Decision
- RIVN Buy
- TECH Buy
- Analyst Count
- RIVN 22
- TECH 8
- Target Price
- RIVN $15.29
- TECH $82.00
- AVG Volume (30 Days)
- RIVN 36.8M
- TECH 781.1K
- Earning Date
- RIVN 02-20-2025
- TECH 01-30-2025
- Dividend Yield
- RIVN N/A
- TECH 0.42%
- EPS Growth
- RIVN N/A
- TECH N/A
- EPS
- RIVN N/A
- TECH 0.95
- Revenue
- RIVN $4,551,000,000.00
- TECH $1,171,583,000.00
- Revenue This Year
- RIVN $6.18
- TECH $7.67
- Revenue Next Year
- RIVN $9.49
- TECH $9.29
- P/E Ratio
- RIVN N/A
- TECH $79.87
- Revenue Growth
- RIVN 20.33
- TECH 2.41
- 52 Week Low
- RIVN $8.26
- TECH $61.16
- 52 Week High
- RIVN $18.86
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- RIVN 53.39
- TECH 55.66
- Support Level
- RIVN $13.01
- TECH $73.67
- Resistance Level
- RIVN $16.65
- TECH $78.44
- Average True Range (ATR)
- RIVN 1.04
- TECH 2.41
- MACD
- RIVN -0.12
- TECH 0.28
- Stochastic Oscillator
- RIVN 37.28
- TECH 66.02
About RIVN Rivian Automotive Inc.
Rivian Automotive Inc designs, develops, and manufactures category-defining electric vehicles and accessories. In the consumer market, the company launched the R1 platform with the first generation of consumer vehicles: the R1T, a two-row, five-passenger pickup truck, and the R1S, a three-row, seven-passenger sport utility vehicle (SUV).
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.